cytarabine has been researched along with Nervous System Diseases in 38 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 20 (52.63) | 18.7374 |
1990's | 6 (15.79) | 18.2507 |
2000's | 7 (18.42) | 29.6817 |
2010's | 5 (13.16) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aramendía, JM; Carranza, OE; Castañón, E; Espinós, J; Fusco, JP; Gil-Bazo, I; Martín, P; Rodríguez, J; Santisteban, M; Zubiri, L | 1 |
Chan, JC; Kwong, YL; Yeung, DY | 1 |
Prömmel, P; Strik, H | 1 |
Kowoll, A; Kuhnhenn, J; Ostermann, K; Pels, H; Schlegel, U | 1 |
Carmona-Iragui, M; Fernández-Torrón, R; Gállego Pérez-Larraya, J; Irimia, P; Martínez-Vila, E; Palma, JA; Panizo, C; Rodríguez-Otero, P | 1 |
Holodny, A; Omuro, A; Palomba, ML; Pentsova, E; Rosenblum, M | 1 |
Abbrederis, K; Apfelbeck, U; Baldinger, C; Buder, R; Burgstaller, S; Duba, C; Eisterer, W; Fiegl, M; Fridrik, M; Gastl, G; Geissler, D; Greil, R; Hausmaninger, H; Hilbe, W; Köck, L; Krieger, O; Kühr, T; Lang, A; Lin, W; Linkesch, W; Lutz, D; Michlmayr, G; Pont, J; Seewann, H; Thaler, J; Zabernigg, A | 1 |
Lange, BJ; Reilly, AF | 1 |
Kishida, S; Ota, K | 1 |
Shapiro, WR; Young, DF | 1 |
Maurach, R; Strian, F | 2 |
Feun, L; Landy, H; Markoe, AM; Snodgrass, SM | 1 |
Cortes-Franco, J; Estey, E; Kornblau, SM | 1 |
Damon, LE; Linker, CA; Ries, CA; Rugo, HS; Smith, GA | 1 |
Alster, Y; Ben-Tal, O; Lowenstein, A; Schwartz, J | 1 |
Achour, E; Azar, N; Belanger, C; Cassoux, N; Delattre, JY; Gerber, S; Hoang-Xuan, K; Leblond, V; Levy, V; Ribrag, V; Soussain, C; Suzan, F | 1 |
Abonour, R; Kim, K; Longo, WL; Mosher, DF; Turman, NJ; Vidarsson, B; Wiersma, SR; Williams, EC; Woodson, RD | 1 |
Luthardt, T; Niederhoff, H; Wehinger, H | 1 |
Aspnes, GT; Kalavsky, SM; Kammerer, BL; Klatskin, EH; McIntosh, S; O'Brien, RT; Pearson, HA; Snead, C | 1 |
Andersen, JW; Berg, DT; Mayer, RJ; Rubin, EH; Schiffer, CA; Stone, RM | 1 |
Bowman, WP; Buchanan, GR; Jacaruso, D; Kamen, BA; Roach, ES; Rollins, N; Winick, NJ | 1 |
Frederick, E | 1 |
Damon, LE; Linker, CA; Mass, R | 1 |
Brochstein, JA; Walker, RW | 1 |
Killander, A; Simonsson, B; Smedmyr, B; Sundström, C | 1 |
Astarloa, L; Barri, A; González Cambaceres, C; Maglio, F; Milani, HL; Pérez Izquierdo, F; Ruggiero, HA; Tallone, JC; Val, A | 1 |
Cabanillas, F; Fridrik, M; Hagemeister, FB; Jagannath, S; McLaughlin, P; Redman, JR; Salvador, P; Swan, F; Tucker, S; Velasquez, WS | 1 |
Fisher, RI; Fisher, SG; Messmore, HL; Nand, S; Patel, R | 1 |
Bagshawe, KD; Crawford, SM; Rustin, GJ | 1 |
Barnett, MJ; Dhaliwal, HS; Ganesan, TS; Lister, TA; Richards, MA; Rohatiner, AZ; Slevin, ML; Smith, BF; Waxman, JH | 1 |
Cáp, J; Cinkovská, S; Foltinová, A; Misíková, Z; Szabová, I | 1 |
Baer, MR; King, LE; Wolff, SN | 1 |
Feun, LG; Hwang, TL; Lee, YY; Martinez-Prieto, J; Yung, WK | 1 |
Koprowski, H | 1 |
Balikhina, GD; Brilliant, MD; Garbuzov, MI; Meshcheriakova, NA; Vorob'ev, IuI | 1 |
Bertino, JR; DeConti, RC; Farber, LR; Levitt, M; Marsh, JC; Mitchell, MS; Skeel, RT | 1 |
Hall, TC | 1 |
7 review(s) available for cytarabine and Nervous System Diseases
Article | Year |
---|---|
Intrathecal chemotherapy for hematologic malignancies: drugs and toxicities.
Topics: Animals; Antineoplastic Agents; Cytarabine; Hematologic Neoplasms; Humans; Injections, Spinal; Methotrexate; Nervous System Diseases | 2009 |
Diagnosis and individualized therapy of neoplastic meningitis.
Topics: Adult; Antineoplastic Agents; Carcinoma; Cerebrospinal Fluid; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Diagnostic Imaging; Female; Humans; Injections, Spinal; Liposomes; Magnetic Resonance Imaging; Male; Meninges; Meningitis; Middle Aged; Neoplasm Invasiveness; Nervous System Diseases; Precision Medicine | 2010 |
Infections with viridans group streptococci in children with cancer.
Topics: Antibiotic Prophylaxis; Child; Child, Preschool; Cytarabine; Humans; Incidence; Leukemia, Myeloid, Acute; Myocarditis; Nervous System Diseases; Neutropenia; Practice Guidelines as Topic; Respiratory Distress Syndrome; Shock, Septic; Stem Cell Transplantation; Streptococcal Infections; Viridans Streptococci | 2007 |
[Drug-induced leukoencephalopathy].
Topics: Antineoplastic Agents; Brain Edema; Cisplatin; Cytarabine; Fluorouracil; Humans; Hypertensive Encephalopathy; Immunosuppressive Agents; Methotrexate; Nervous System Diseases; Syndrome | 2007 |
Neurological complications of antineoplastic therapy.
Topics: Adrenal Cortex Hormones; Alkylating Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Aspartic Acid; Cisplatin; Cytarabine; Fluorouracil; Humans; Methotrexate; Nervous System Diseases; Phosphonoacetic Acid; Thymidine; Vinblastine; Vincristine | 1984 |
[Cytostatic therapy: neurologic and psychiatric syndromes].
Topics: Antineoplastic Agents; Asparaginase; Cyclophosphamide; Cytarabine; Dacarbazine; Dactinomycin; Doxorubicin; Fluorouracil; Humans; Methotrexate; Nervous System Diseases; Nitrosourea Compounds; Procarbazine; Psychoses, Substance-Induced; Vincristine | 1980 |
Neurologic complications of immunosuppressive agents.
Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal; Cyclosporins; Cytarabine; Humans; Immunosuppressive Agents; Methotrexate; Muromonab-CD3; Nervous System Diseases | 1988 |
5 trial(s) available for cytarabine and Nervous System Diseases
Article | Year |
---|---|
A randomized study comparing interferon (IFN alpha) plus low-dose cytarabine and interferon plus hydroxyurea (HU) in early chronic-phase chronic myeloid leukemia (CML).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Female; Gastrointestinal Diseases; Hematologic Diseases; Humans; Hydroxyurea; Interferon-alpha; Leukemia, Myeloid, Chronic-Phase; Life Tables; Male; Middle Aged; Nervous System Diseases; Recombinant Proteins; Treatment Outcome | 2003 |
Results of intensive chemotherapy followed by hematopoietic stem-cell rescue in 22 patients with refractory or recurrent primary CNS lymphoma or intraocular lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Central Nervous System Neoplasms; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Eye Neoplasms; Feasibility Studies; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Immunoblastic; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Nervous System Diseases; Salvage Therapy; Thiotepa | 2001 |
Risk factors for high-dose cytarabine neurotoxicity: an analysis of a cancer and leukemia group B trial in patients with acute myeloid leukemia.
Topics: Acute Disease; Adult; Age Factors; Aged; Alkaline Phosphatase; Aspartate Aminotransferases; Creatinine; Cytarabine; Female; Humans; Leukemia, Myeloid; Male; Middle Aged; Nervous System Diseases; Risk Factors | 1992 |
Neurotoxicity of high-dose cytosine arabinoside.
Topics: Adult; Aged; Clinical Trials as Topic; Cytarabine; Female; Humans; Male; Middle Aged; Nervous System Diseases; Syndrome | 1985 |
Combination sequential chemotherapy in advanced reticulum cell sarcoma.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Alopecia; Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Drug Combinations; Female; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Nervous System Diseases; Radiography, Thoracic; Remission, Spontaneous; Vincristine | 1972 |
26 other study(ies) available for cytarabine and Nervous System Diseases
Article | Year |
---|---|
Neurological and cytological response as potential early predictors of time-to-progression and overall survival in patients with leptomeningeal carcinomatosis treated with intrathecal liposomal cytarabine: a retrospective cohort study.
Topics: Adolescent; Adult; Aged; Antimetabolites, Antineoplastic; Cytarabine; Cytodiagnosis; Disease Progression; Female; Follow-Up Studies; Humans; Injections, Spinal; Liposomes; Male; Meningeal Carcinomatosis; Middle Aged; Neoplasm Staging; Neoplasms; Nervous System Diseases; Prognosis; Remission Induction; Retrospective Studies; Survival Rate; Young Adult | 2013 |
Neurologic complications after intrathecal liposomal cytarabine in combination with systemic polychemotherapy in primary CNS lymphoma.
Topics: Aged; Antimetabolites, Antineoplastic; Central Nervous System Neoplasms; Cytarabine; Drug Therapy, Combination; Female; Humans; Injections, Spinal; Liposomes; Lymphoma; Male; Middle Aged; Nervous System Diseases | 2011 |
Neurologic complications of intrathecal liposomal cytarabine administered prophylactically to patients with non-Hodgkin lymphoma.
Topics: Aged; Antimetabolites, Antineoplastic; Cytarabine; Female; Follow-Up Studies; Humans; Injections, Spinal; Liposomes; Lymphoma, Non-Hodgkin; Male; Middle Aged; Nervous System Diseases; Ophthalmoscopes; Retrospective Studies | 2011 |
Chemotherapy-related magnetic resonance imaging abnormalities mimicking disease progression following intraventricular liposomal cytarabine and high dose methotrexate for neurolymphomatosis.
Topics: Aged; Antineoplastic Agents; Autopsy; Brain; Brain Injuries; Chlorambucil; Cytarabine; Disease Progression; Fatal Outcome; Humans; Injections, Spinal; Leukemia, Lymphocytic, Chronic, B-Cell; Magnetic Resonance Imaging; Male; Methotrexate; Nervous System Diseases; Positron-Emission Tomography; Recurrence; Waldenstrom Macroglobulinemia | 2012 |
[Neurotoxic side effects of cytostatic therapy (author's transl)].
Topics: Antineoplastic Agents; Asparaginase; Cyclophosphamide; Cytarabine; Dacarbazine; Dactinomycin; Doxorubicin; Fluorouracil; Humans; Meningitis; Methotrexate; Nervous System Diseases; Nitrosourea Compounds; Procarbazine; Vincristine | 1981 |
Neurologic complications of Merkel cell carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Merkel Cell; Cytarabine; Fatal Outcome; Humans; Leucovorin; Magnetic Resonance Imaging; Male; Meningeal Neoplasms; Methotrexate; Middle Aged; Nervous System Diseases; Skin Neoplasms | 1994 |
Neurotoxicity associated with fludarabine and cytosine arabinoside chemotherapy for acute leukemia and myelodysplasia.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Cytarabine; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Myelodysplastic Syndromes; Nervous System Diseases; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Vidarabine | 1993 |
High-dose cytarabine dose modification reduces the incidence of neurotoxicity in patients with renal insufficiency.
Topics: Adult; Antimetabolites, Antineoplastic; Cytarabine; Drug Administration Schedule; Female; Humans; Incidence; Male; Middle Aged; Neoplasms; Nervous System Diseases; Renal Insufficiency; Retrospective Studies; Risk Factors | 1997 |
Visual loss following high-dose cytosine arabinoside (ARA-C)
Topics: Adult; Cytarabine; Female; Humans; Leukemia, Myeloid, Acute; Nervous System Diseases; Vision Disorders | 2000 |
Fludarabine and cytarabine as a sequential infusion regimen for treatment of adults with recurrent, refractory or poor prognosis acute leukemia.
Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Cytarabine; Cytogenetic Analysis; Disease-Free Survival; Drug Administration Schedule; Female; Hematologic Diseases; Humans; Infections; Infusion Pumps; Leukemia; Lung Diseases; Male; Middle Aged; Nervous System Diseases; Prognosis; Recurrence; Retrospective Studies; Survival Rate; Treatment Outcome; Vidarabine | 2001 |
Severe hemorrhagic varicella with visceral involvement: virological and serological studies during treatment with cytosine arabinoside.
Topics: Adolescent; Chickenpox; Cytarabine; Hemorrhage; Herpesvirus 3, Human; Humans; Kidney Diseases; Lung Diseases; Male; Nervous System Diseases; Skin | 1976 |
Chronic neurologic disturbance in childhood leukemia.
Topics: Adolescent; Antineoplastic Agents; Child; Cyclophosphamide; Cytarabine; Folic Acid; Humans; Learning Disabilities; Leukemia; Leukemia, Lymphoid; Methotrexate; Movement Disorders; Nervous System Diseases; Prospective Studies; Radiotherapy; Seizures; Time Factors | 1976 |
Unexpected acute neurologic toxicity in the treatment of children with acute lymphoblastic leukemia.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cytarabine; Etoposide; Female; Humans; Infant; Leucovorin; Male; Methotrexate; Nervous System Diseases; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1992 |
Rare neurotoxicity related to intrathecal Cytosar.
Topics: Adult; Cytarabine; Female; Humans; Injections, Spinal; Nervous System Diseases; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1991 |
The association between high-dose cytarabine neurotoxicity and renal insufficiency.
Topics: Acute Kidney Injury; Alcoholism; Cytarabine; Female; Humans; Hyperbilirubinemia; Leukemia, Myeloid, Acute; Male; Middle Aged; Nervous System Diseases; Risk Factors | 1989 |
Aggressive treatment improves survival in adult acute lymphoblastic leukemia.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Blood Transfusion; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Evaluation; Humans; Meningeal Neoplasms; Mercaptopurine; Methotrexate; Middle Aged; Nervous System Diseases; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Remission Induction; Vincristine | 1988 |
[Treatment of neurological forms of Argentinian hemorrhagic fever with cytarabine].
Topics: Adult; Aged; Cytarabine; Encephalitis, Arbovirus; Hemorrhagic Fever, American; Humans; Middle Aged; Nervous System Diseases; Time Factors | 1987 |
Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP).
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Cisplatin; Cytarabine; Dexamethasone; Drug Evaluation; Humans; Lymphoma; Middle Aged; Multiple Organ Failure; Nervous System Diseases | 1988 |
Neurotoxicity associated with systemic high-dose cytosine arabinoside.
Topics: Acute Disease; Adolescent; Adult; Aged; Cytarabine; Dose-Response Relationship, Drug; Female; Humans; Leukemia; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Male; Middle Aged; Nervous System Diseases | 1986 |
Acute neurological toxicity of intrathecal cytosine arabinoside. A case report.
Topics: Acute Disease; Adult; Brain Neoplasms; Cytarabine; Humans; Male; Nervous System Diseases | 1986 |
Consequences of intensive therapy of acute lymphoblastic leukemia in children in initial complete remission lasting more than five years.
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Child; Child, Preschool; Combined Modality Therapy; Cytarabine; Female; Humans; Leukemia, Lymphoid; Male; Mental Disorders; Mercaptopurine; Methotrexate; Nervous System Diseases; Prednisone; Time Factors; Vincristine | 1985 |
Palmar-plantar erythrodysesthesia and cytarabine.
Topics: Cytarabine; Erythema; Foot Dermatoses; Hand Dermatoses; Humans; Nervous System Diseases; Sensation | 1985 |
Neurotoxicity of high-dose Ara-C and intracarotid chemotherapy.
Topics: Carotid Arteries; Cytarabine; Humans; Infusions, Intra-Arterial; Nervous System Diseases | 1985 |
Chronic viral neuropathies: models for study and food for thought.
Topics: Animals; Antiviral Agents; Cattle; Chick Embryo; Cricetinae; Cytarabine; Cytomegalovirus; Dactinomycin; Deoxyuridine; Disease Models, Animal; DNA, Viral; Encephalitis Viruses; Friend murine leukemia virus; Humans; Imidazoles; Interferons; Mice; Mitomycins; Nervous System Diseases; Parainfluenza Virus 1, Human; Phenylalanine; Prions; Respirovirus; RNA Viruses; RNA, Viral; Vesicular stomatitis Indiana virus; Viral Interference; Virus Diseases | 1969 |
[Neuroleukemia].
Topics: Adolescent; Adult; Child; Child, Preschool; Cytarabine; Humans; Leukemia; Leukemia, Lymphoid; Meninges; Methotrexate; Nervous System Diseases; Radioisotope Teletherapy; Remission, Spontaneous | 1974 |
Use of cancer chemotherapeutic agents in non-neoplastic diseases.
Topics: Antineoplastic Agents; Autoimmune Diseases; Cell Division; Cytarabine; DNA Replication; Graft Rejection; Humans; Mycoses; Nervous System Diseases; Nitrogen Mustard Compounds; Parasitic Diseases; Psoriasis; Skin Diseases; Virus Diseases | 1973 |